

HY-153519 · 50 mg
MedChemExpress · Cat: HY-153519
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/wwl0245.htmlDescription
WWL0245 is a potent and seletive BRD4 PROTAC. WWL0245 selectively degrades BRD4 with sub-nanomolar DC50 1 nM than BRD2/3 and PLK1 DC50 1 ?M . WWL0245 shows excellent selective cytotoxicity in the BETi sensitive cancer cell lines, including AR-positive prostate cancer cell lines. WWL0245 is a promising drug candidate for AR-positive prostate cancer research and a valuable tool compound to study the biological function of BRD4.

